Skip to content

Total Assets at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$3.45B+22.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.37B+55.5%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$1.23B+23.1%
Royalty Pharma logo
Royalty PharmaRPRX
$19.82B+12.5%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's total assets?
Arrowhead Research (ARWR) reported total assets of $2.27B in Q1 2026.
How has Arrowhead Research's total assets changed year-over-year?
Arrowhead Research's total assets increased by 44.2% year-over-year, from $1.57B to $2.27B.
What is the long-term trend for Arrowhead Research's total assets?
Over 5 years (2020 to 2025), Arrowhead Research's total assets has grown at a 21.5% compound annual growth rate (CAGR), from $522.5M to $1.39B.
What does total assets mean?
The total value of everything the company owns.
How do you interpret total assets?
Growth in total assets generally indicates company expansion, though it must be evaluated alongside liabilities to determine net worth.
How does total assets compare across companies?
Used as a baseline for calculating return on assets (ROA) and assessing the overall size of the company relative to industry peers.